Table 1.
Details of the numbers of animals included in each exdperimental group
| Tartaric acid infused from 125 days gestation | Metyrapone infused from 125 days gestation | Metyrapone infused from 137/138 days gestation | |
|---|---|---|---|
| Surgery | 11 | 10 | 9 |
| Singleton (S)/twin (T) pregnancies | S(9), T(2) | S(10) | S(7), T(2) |
| Sex | M(3), F(7) | M(4), F(4), | M(5), F(4) |
| unknown(1) | unknown(2) | ||
| Measurement of arterial BP at 126-127 days | 9 | 10 | Not applicable |
| Measurement of arterial BP at 137-139 days | 6 | 7 | 7 |
| AII administration at 137-139 days | 7 | 7 | 7 |
| Measurement of fetal plasma ACTH at 125-128 days | 7 | 8 | Not applicable |
| Measurement of fetal plasma 11-desoxycortisol at 125-128 days | 7 | 9 | Not applicable |
| Measurement of fetal plasma cortisol at 125-128 days | 7 | 9 | Not applicable |
| Measurement of fetal plasma ACTH at 137-140 d | 6 | 9 | 8 |
| Measurement of fetal plasma 11-desoxycortisol at 137-140 days | 6 | 9 | 8 |
| Measurement of fetal plasma cortisol at 137-140 days | 6 | 9 | 8 |
| Measurement of fetal plasma glucose | 8 | 10 | 7 |
| Measurement of maternal plasma progesterone at 137-140 days | 5 | 5 | 5 |
| Measurement of fetal organ weights at 140-141 days | 6 | 7 | 8 |